MedPath

Effects of Animal-assisted Therapy on Brain-injured Patients

Not Applicable
Completed
Conditions
Impaired Social Functioning
Interventions
Other: standard therapy
Other: animal assisted therapy
Registration Number
NCT02599766
Lead Sponsor
Swiss Tropical & Public Health Institute
Brief Summary

The purpose is to investigate whether animal-assisted therapy has positive biopsychosocial effects on patients with brain injuries. This study investigates the short-term biopsychosocial effects that occur when animals are present during therapy sessions in comparison to therapy sessions without animals, observing a group of 25 patients over 24 therapy sessions. While half of the sessions are held in presence of an animal and half without, they are as comparable as possible with respect to content and setting. In this study, patients who are in a slightly advanced rehabilitation process, assessed via their function profile, are investigated.

Detailed Description

This study is designed as a controlled cross-over, within-subject trial with repeated measurement. The experimental condition is the standardised therapy session using therapy animals (AAT), while the control condition is the comparable "standard" therapy session without the presence of an animal.

Over a period of six weeks, patients have four standardised therapy sessions per week, that alternate in a way that two sessions in two consecutive weeks are similar except for one is with the presence of animals and one without. In this way, data is collected over 24 therapy sessions (12 experimental, 12 control) for each patient.

Each therapy session lasts 30 minutes with an additional 5 minutes before and 10 minutes after the session for filling in the questionnaires.

The study takes place at REHAB Basel. Animal-assisted therapies will be held at the "Therapie-Tiergarten" at REHAB Basel in the presence of one or more animals that will be selected by the therapist and the patient together and with which the patient has a relationship.

Patients who are willing to join the study will be selected and allocated randomly to start with either the experimental or the control condition.

Participation in the study will be cancelled if a patient wishes to do so or if they choose to withdraw from the animal-assisted therapy program. Other criteria for withdrawal are if the patient is harmed by an animal or if the animals are abused by the patient.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • patient at REHAB Basel
  • brain-injury
  • willing to participate in animal-assisted therapies
  • physical and psychological resilience and ability to go/be transported outside to the "Therapie-Tiergarten"
  • ability to get in contact with the animal autonomously
Exclusion Criteria
  • medical contraindications:allergies, phobias, etc.
  • no willingness to participate in animal-assisted therapies
  • patient might present a danger to the animals (aggressive behaviour)
  • patient's medication changes radically during the time of data collection

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
standard therapystandard therapy"Standard therapy" without the presence of an animal.
animal assisted therapyanimal assisted therapy"Standard therapy" that is done in the presence and with integrating an animal.
Primary Outcome Measures
NameTimeMethod
Social Functioning: Total Social Behavior6 weeks

Interaction and communication behavior is assessed via video coding in Noldus Observer. Percentage of all social behaviors are collected and aggregated to one measure, the total social behavior.

Secondary Outcome Measures
NameTimeMethod
Social Functioning: Verbal Communication6 weeks

Interaction and communication behavior is assessed via video coding in Noldus Observer. Percentages of the defined verbal behaviors is collected and aggregated to one measure.

Social Functioning: Nonverbal Communication6 weeks

Interaction and communication behavior is assessed via video coding in Noldus Observer. Percentage of the defined nonverbal behaviors is collected and aggregated to one measure.

Social Functioning: Physical Contact6 weeks

Interaction and communication behavior is assessed via video coding in Noldus Observer. Percentage of the defined physical contact is collected and aggregated to one measure.

Social Functioning: Attention6 weeks

Interaction and communication behavior is assessed via video coding in Noldus Observer. Percentage of the defined attention behavior is collected and aggregated to one measure.

Negative Emotional Display6 weeks

Emotional display is assessed via video coding in Noldus Observer. Percentage of the defined behavior during the therapy sessions is collected and aggregated to one measure of negative emotion.

Neutral Emotional Display6 weeks

Emotional display is assessed via video coding in Noldus Observer. Percentage of the defined behavior during the therapy sessions is collected and aggregated to one measure of neutral emotion.

Mood 4: Satisfaction Therapist Rating6 weeks

Satisfaction during the therapy sessions was assessed by the therapist using a VAS ranging from 0 (unsatisfied) to 160 (satisfied).

Positive Emotional Display6 weeks

Emotional display is assessed via video coding in Noldus Observer. Percentage of the defined behavior during the therapy sessions is collected and aggregated to one measure of positive emotion.

Mood 1: Motivation6 weeks

Assessed via visual analogue scale as self-rating Scale ranging from 0 (not motivated) to 160 (highly motivated)

Mood 2: Bipolar Mood Dimension (Good-bad)6 weeks

Assessed via the Mehrdimensionaler Befindlichkeitsfragebogen (MDBF) We analysed the bipolar mood dimension (good-bad) ranging from 4 (not at all good mood) to 20 (very good mood).

Heart Rate6 weeks

Assessed via EKG (Polar) during the sessions and measured in beat/min.

Mood 3: Satisfaction Self-assessment6 weeks

Assessed via visual analogue scale as rating by the therapist Satisfaction during the therapy sessions was assessed by the patient themselves using a VAS ranging from 0 (unsatisfied) to 160 (satisfied).

Motor Activity6 weeks

Assessed via actimeter at the patients wrist during sessions, measuring acceleration of the hand. It records data in 15-s epochs for maximum sensitivity. Data were calculated to yield average activity Counts per minute.

Trial Locations

Locations (1)

REHAB Basel

🇨🇭

Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath